Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference

Before you go, we thought you'd like these...
Before you go close icon

Celgene Corporation to Present at the 31stAnnual J.P. Morgan Healthcare Conference

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (Nasdaq: CELG) today announced its presentation at the 31st Annual J.P. Morgan Healthcare Conference on January 7, 2013 at 11:00a.m. E.T. will be webcast live and will be available in the investor relations section of the company's Web site at www.celgene.com. Celgene management will provide an overview of the company.

About Celgene


Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com.

anImage


Celgene Corporation
Jacqualyn A. Fouse, Ph.D, 908-673-9956
EVP, Chief Financial Officer
or
Patrick E. Flanigan III, 908-673-9969
VP, Investor Relations

KEYWORDS:   United States  North America  New Jersey

INDUSTRY KEYWORDS:

The article Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners